Pioglitazone and the secondary prevention of cardiovascular disease. A meta-analysis of randomized-controlled trials

BACKGROUND AND AIMS: Pioglitazone targets multiple pathogenic pathways involved in the development of cardiovascular diseases (CVD). The aim of this systematic review and meta-analysis is to assess the effects of pioglitazone treatment on the secondary prevention of CVD. METHODS: Randomized-controll...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cardiovasc Diabetol
Autori principali: de Jong, Marit, van der Worp, H. Bart, van der Graaf, Yolanda, Visseren, Frank L. J., Westerink, Jan
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2017
Soggetti:
Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5644073/
https://ncbi.nlm.nih.gov/pubmed/29037211
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-017-0617-4
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi